Project Grant R00CA267181
Award Date
1/1/25
Completion Date
12/31/27
Dollars Obligated
$224K
Federal Agency
National Cancer Institute
Federal Grant Program
93.395
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
This National Cancer Institute (NCI) Project Grant award under CFDA 93.395 "Cancer Treatment Research" provides $196,267 in funding to the University of California, Irvine (UCI) to advance novel cancer prevention and therapeutic strategies across NCI's clinical trial networks. The award will support the Principal Investigator's leadership roles on key NCI committees, completion of an ongoing Phase III clinical trial focused on preventing colorectal adenomas in a racially/ethnically...
This Project Grant award, valued at $625,452.00 and effective January 1, 2025, was provided by the National Institute on Aging (CFDA 93.866 - Aging Research) to the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. The funding supports a research project to develop and evaluate a clinical decision support intervention to guide colorectal cancer screening decisions in older adults, with a focus on incorporating life expectancy considerations. The project will involve...
This federal Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower program) provides $197,640 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to develop implementation strategies to initiate colorectal cancer (CRC) screening in previously unscreened individuals aged 45 to 54 at a predominantly Black community health center in Boston, Massachusetts. The key objectives are to: (1) identify system-level determinants of...
This Project Grant award from the National Cancer Institute (CFDA 93.393 Cancer Cause and Prevention Research) provides $637,596.00 to develop and test an intervention to reduce cancer information avoidance and increase colorectal cancer screening. The intervention is a video-based strategy designed to increase self-efficacy and positive affect, thereby reducing defensive avoidance of colorectal cancer information. The project involves a randomized controlled trial (RCT) to evaluate the...
This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $696,852 to Harvard T.H. Chan School of Public Health to optimize a mobile messaging intervention to increase colorectal cancer (CRC) screening rates among patients at community health centers (CHCs). The project aims to use a two-phase process to first focus on maximizing patient engagement with a text message-based CRC screening campaign, and then use a factorial design...
This federal Project Grant award of $622,913 from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program will fund a 5-year study to evaluate a multilevel intervention to increase colonoscopic follow-up after abnormal stool-based colorectal cancer screening in a community safety-net setting. The study will be conducted by the University of California, Los Angeles (UCLA) in partnership with the Northeast Valley Health Corporation (NEVHC), a...
This federal Project Grant award, with ID R37CA300540, was provided by the National Cancer Institute (CFDA 93.394, Cancer Detection and Diagnosis Research program) to the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. The $564,414 award, effective from April 1, 2025 to March 31, 2030, supports research with two key objectives: 1) Developing and validating a predictive model using electronic health record data to accurately identify individuals at high risk for...
This Project Grant award of $5,151,564 from the National Cancer Institute (CFDA 93.397 Cancer Centers Support Grants) aims to conduct a Translational Research Program in Colorectal Cancer Disparities. The program will: Improve risk-stratified screening and early detection of colorectal cancer across racial and ethnic populations by developing risk prediction models. Reduce racial and ethnic disparities in colorectal cancer mortality by discovering and validating novel molecular and biological...
This $2,136,715 Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) is focused on harnessing DNA methylation in peripheral blood to improve colorectal cancer prevention. The primary awardee, President and Fellows of Harvard College through its Harvard T.H. Chan School of Public Health, will lead the research effort. Key sub-awards have been made to Dana-Farber Cancer Institute and Boston University to contribute...
This federal Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) provides $670,534 to Northwestern University to develop an optical hyperspectral nanoscale chromatin analysis technology for colorectal cancer risk-stratification. The goal is to create a highly accurate, low-cost screening test that can be administered in primary care settings to identify patients who should undergo colonoscopy, with a target of 99.5% negative predictive...